# Hh and EGFR-Ras signaling promote distinct steps of tumor progression in the Drosophila follicle epithelium

**Authors:** Sari Anschütz, Hannah Müller, Andrea Schubert, Jobelle M. Peralta, Todd G. Nystul, Katja Rust

PMC · DOI: 10.1038/s41467-026-70844-y · 2026-03-24

## TL;DR

This study explores how two signaling pathways, Hh and EGFR-Ras, contribute to tumor progression in fruit fly ovarian cells by affecting cell differentiation and tissue structure.

## Contribution

The study reveals how Hh and EGFR-Ras signaling pathways converge at the transcriptional level to drive tumor-like growth in Drosophila follicle cells.

## Key findings

- Hedgehog signaling promotes an undifferentiated state and induces partial epithelial-mesenchymal transition.
- EGFR-Ras overactivation causes cell cycle defects and blocks differentiation.
- Combined pathway overactivation leads to tumor-like growth with loss of tissue architecture and host lifespan reduction.

## Abstract

Controlled signaling activity is vital for normal tissue homeostasis and oncogenic signaling activation facilitates tumorigenesis. Here, we combine single-cell transcriptomics with in-depth genetic and imaging analysis to investigate the role of the EGFR-Ras and Hedgehog signaling pathways in homeostasis of the Drosophila follicle stem cell lineage. We find that Hedgehog signaling simultaneously promotes an undifferentiated state and induces differentiation via activation of the epithelial-mesenchymal-transition associated transcription factor Zfh1. Overactivation of Hedgehog signaling generates a mixed transcriptional state comparable to partial epithelial-mesenchymal-transition. EGFR-Ras overactivation induces cell cycle defects by activating the transcription factors Pointed and E2f1 and impedes differentiation. Overactivation of both pathways blocks differentiation and induces tumor-like growth where follicle cells exhibit a loss of tissue architecture, sustained proliferation and a reduced lifespan of the host. These findings provide new insight into how signaling pathways converge at the transcriptional level to prevent malignant cell behavior.

Aberrant signaling pathway activation is a key driver of tumorigenesis. Using single-cell RNA sequencing, the authors unravel how EGFR-Ras and Hedgehog signaling promote distinct steps of tumor progression in a Drosophila ovarian tumor model.

## Linked entities

- **Genes:** FUT1 (fucosyltransferase 1 (H blood group)) [NCBI Gene 2523], zfh1 (Zn finger homeodomain 1) [NCBI Gene 43650], pnt (pointed) [NCBI Gene 42757], E2F1 (E2F transcription factor 1) [NCBI Gene 1869]
- **Species:** Drosophila (taxon 7215)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, DSPP (dentin sialophosphoprotein) [NCBI Gene 1834] {aka DFNA39, DGI1, DMP3, DPP, DSP}, C6orf15 (chromosome 6 open reading frame 15) [NCBI Gene 29113] {aka STG}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, Wnt2 (Wnt oncogene analog 2) [NCBI Gene 35975] {aka CG1916, D-wnt-2, DWnt-2, DWnt2, Dm DWnt2, Dm-2}, zfh1 (Zn finger homeodomain 1) [NCBI Gene 43650] {aka CG1322, Dmel\CG1322, ZFH-1, Zfh-1, Zfh1a, l(3)00865}, SRPRA (SRP receptor subunit alpha) [NCBI Gene 6734] {aka DP, SRPR, Sralpha}, TUB (TUB bipartite transcription factor) [NCBI Gene 7275] {aka RDOB, rd5}, HTL (high L-leucine transport) [NCBI Gene 3343] {aka HLT, LEUT}, rl (rolled) [NCBI Gene 3354888] {aka 12559, BcDNA:RE08694, CG12559, CG18732, CT34260, CT39192}, CTNND1 (catenin delta 1) [NCBI Gene 1500] {aka BCDS2, CAS, CTNND, P120CAS, P120CTN, p120}, SPARC (secreted protein acidic and cysteine rich) [NCBI Gene 6678] {aka BM-40, OI17, ON, ONT}, DLG1 (discs large MAGUK scaffold protein 1) [NCBI Gene 1739] {aka DLGH1, SAP-97, SAP97, hdlg}, eya (eyes absent) [NCBI Gene 33916] {aka 24582246, BcDNA:LD16029, CG9554, CLI, CLIFT, Clift}, hpo (hippo) [NCBI Gene 37247] {aka CG11228, Dmel\CG11228, Hippo, Hpo/Wts, MST, MST2}, LMNA (lamin A/C) [NCBI Gene 4000] {aka CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL}, Fas3 (Fasciclin 3) [NCBI Gene 35097] {aka CG5803, Dmel\CG5803, FAS III, FASIII, Fas, Fas III}, PARD3 (par-3 family cell polarity regulator) [NCBI Gene 56288] {aka ASIP, Baz, PAR3, PAR3alpha, PARD-3, PARD3A}, Lkb1 (Lkb1 kinase) [NCBI Gene 41673] {aka CG9374, DmLKB1, Dmel\CG9374, LKB1/PEUTZ JEGHERS KINASE, PAR-4, PAR4}, CFP (complement factor properdin) [NCBI Gene 5199] {aka BFD, PFC, PFD, PROPERDIN}, WNT4 (Wnt family member 4) [NCBI Gene 54361] {aka SERKAL, WNT-4}, cas (castor) [NCBI Gene 44018] {aka CG2102, Dmel\CG2102, l(3)j1C2, l(3)neo33, ming}, Egfr (Epidermal growth factor receptor) [NCBI Gene 37455] {aka C-erb, CG10079, D-EGFR, D-Egf, DEGFR, DER}, FZR1 (fizzy and cell division cycle 20 related 1) [NCBI Gene 51343] {aka CDC20C, CDH1, DEE109, FZR, FZR2, HCDH}, CDK1 (cyclin dependent kinase 1) [NCBI Gene 983] {aka CDC2, CDC28A, P34CDC2}, E2f1 (E2F transcription factor 1) [NCBI Gene 42550] {aka CG6376, DRTF1/E2F, DmE2F-1, Dmel\CG6376, Dp, E(Sev-CycE)3A}, SMO (smoothened, frizzled class receptor) [NCBI Gene 6608] {aka CRJS, FZD11, Gx, PHLS, SMOH}, AURKB (aurora kinase B) [NCBI Gene 9212] {aka AIK2, AIM-1, AIM1, ARK-2, ARK2, AurB}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, Cse1 (Chromosome segregation 1) [NCBI Gene 35016] {aka BcDNA:LD14270, CAS, CG13281, Cas, Dcas, Dmel\CG13281}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, FBXL15 (F-box and leucine rich repeat protein 15) [NCBI Gene 79176] {aka FBXO37, Fbl15, JET}, Ras85D (Ras oncogene at 85D) [NCBI Gene 41140] {aka C-ras1, CG9375, D-Ras, D-Ras1, D-ras-1, D-ras1}, PEK (pancreatic eIF-2alpha kinase) [NCBI Gene 40653] {aka CG2087, DPERK, DmPEK, Dmel\CG2087, DpERK, PEK1}, UROD (uroporphyrinogen decarboxylase) [NCBI Gene 7389] {aka PCT, UPD}, pnt (pointed) [NCBI Gene 42757] {aka 0123/09, 0608/07, 0998/12, 3520, CG17077, D-Ets-2}, E2F1 (E2F transcription factor 1) [NCBI Gene 1869] {aka E2F-1, RBAP1, RBBP3, RBP3}, hh (hedgehog) [NCBI Gene 42737] {aka CG4637, Dmel\CG4637, Dmhh, Hg, Mir, Mrt}, RNF217-AS1 (RNF217 antisense RNA 1) [NCBI Gene 7955] {aka STL}, ZHX2 (zinc fingers and homeoboxes 2) [NCBI Gene 22882] {aka AFR1, RAF}, F9 (coagulation factor IX) [NCBI Gene 2158] {aka F9 p22, FIX, HEMB, P19, PTC, THPH8}, AMPKalpha (AMP-activated protein kinase alpha subunit) [NCBI Gene 43904] {aka AK, AMPK, AMPK alpha, AMPK-alpha, Ampk, CG3051}
- **Diseases:** inflammation (MESH:D007249), ovarian tumor (MESH:D010051), hyperplasia (MESH:D006965), cancer (MESH:D009369), WT (MESH:D009396), MBs (MESH:C567291), dysplasia (MESH:D015792), MB (MESH:D003324), tumorigenesis (MESH:D063646), metastasis (MESH:D009362), cyst (MESH:D003560)
- **Chemicals:** PBS (MESH:D007854), DAPI (MESH:C007293), agarose (MESH:D012685), 7P-S (-), Triton X-100 (MESH:D017830), Phalloidin (MESH:D010590)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Rattus norvegicus (brown rat, species) [taxon 10116], Diptera (flies, order) [taxon 7147], Homo sapiens (human, species) [taxon 9606], Drosophila melanogaster (fruit fly, species) [taxon 7227], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** S250A, S168A

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13018590/full.md

---
Source: https://tomesphere.com/paper/PMC13018590